Pfizer-BioNTech vaccine may get approval from British regulators this week. | UK |

November 23, 2020 10:09 PM AEDT | By Team Kalkine Media

Google News:

Recent News

Sofdra™ Gains Traction: Botanix Pharmaceuticals (ASX:BOT) Reports Posi...

Stavely Minerals (ASX:SVY) Advances Fairview Gold Prospect Exploration

Radisson Hotel Group opens Radisson Hotel Don Mueang Bangkok, strength...

SKYWORTH PV Launches ฿1B Local Solar Target and $500M ASEAN Clean Ener...

Pfizer-BioNTech’s Covid-19 vaccine may get regulatory approval in Britain as early as this week. It has been reported that the vaccine candidate will get a go-ahead in the UK even before the US authorizes it.

John Laing Group plc to increase stake in I-77 Mobility Partners

John Laing Group plc has pledged to invest an additional US$38.6 million to increase its shareholding in I-77 Mobility Partners. The group is acquiring 7.45 percent of the interest in I-77 Mobility Partners from an existing partner, which will increase its overall stake in the project to 17.45 percent. I-77 Mobility Partners is developing I-77 Express Lanes, a public-private partnership project with the North Carolina Department of Transportation, and will be operating it.

Greencoat UK Wind Plc to acquire 49% stake in Humber Gateway offshore wind farm

The company has agreed to the acquisition in association with several pension funds investing through a fund also controlled by Greencoat Capital. As per the agreement, Greencoat UK will acquire a net 38 percent stake in the wind farm for consideration of £500 million, including cash and working capital.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.